Camurus Overview
- Founded
- 1991
- Status
- Public
- Employees
- 134
- Stock Symbol
- CAMX
- Share Price
- $25.22
- (As of Friday Closing)
Camurus General Information
Description
Camurus AB is a research and development focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032 and others. The company's geographical segments include Europe (of which Sweden), the United States, Japan, Australia, and Other geographical areas.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
STO
Primary Office
- Ideon Science Park
- SE-223 70
- Lund
- Sweden
+46 046-286 00 00
Camurus Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $25.22 | $26.26 | $5.88 - $28.42 | $1.37B | 54.2M | 121K | -$0.36 |
Camurus Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 1,130,406 | 449,717 | 261,337 | 568,976 |
| Revenue | 28,032 | 11,165 | 5,668 | 6,354 |
| EBITDA | (21,441) | (37,111) | (32,498) | (28,015) |
| Net Income | (18,338) | (30,646) | (26,971) | (22,298) |
| Total Assets | 110,310 | 82,575 | 40,576 | 58,135 |
| Total Debt | 2,647 | 2,923 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Camurus Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Camurus‘s full profile, request access.
Request a free trialCamurus Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Camurus AB is a research and development focused pharmaceutical company. It develops pharmaceuticals for the treatment o
Drug Discovery
Lund, Sweden
134
As of 2020
000.00
0000
0000-00-00
00000000
000.00
00000
pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit
000000000000000
Uppsala, Sweden
000
As of 0000
000.00
0000
0000-00-00
00000000
000.00
00000 00
m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
0000 000000000
Mumbai, India
00000
As of 0000
00000
0.000
0000-00-00
00000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialCamurus Competitors (26)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Orexo | Formerly VC-backed | Uppsala, Sweden | 000 | 000.00 | 00000000 | 000.00 |
| 00000 000000000000 | Formerly PE-Backed | Mumbai, India | 00000 | 00000 | 00000000 | 00000 |
| 0000000000 0000000 | Corporation | Ingelheim am Rhein, Germany | 00000 | |||
| 000000-0000000 000 | Corporation | Karachi, Pakistan | 0000 | |||
| 0000000 | Corporate Backed or Acquired | Raritan, NJ | 00000 | 000000&0 |
Camurus Executive Team (4)
Camurus Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCamurus Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Camurus‘s full profile, request access.
Request a free trial